跳至主要内容
临床试验/NCT04265937
NCT04265937招募中不适用

Screening of Genetic Susceptibility Genes for Breast Cancer Patients and Establishment of High-risk Populations in Chinese Communities

Fudan University1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
1
主要终点
The frequency of pathogenic or likely pathogenic variants of BRCA1/2 and other genetic susceptibility genes in Chinese community breast cancer population

研究概览

简要总结

This is a community-based prospective study and the research object is breast cancer patients. It is planned to take the community as the unit to inform and collect the breast cancer patients who voluntarily participate to carry out the detection of BRCA1, BRCA2, PTEN, CHEK2 and PALB2 genes through the community health service center.

详细描述

This is a population-based, prospective, cohort study which has been ongoing in 3 provinces of eastern China since 2019. Up to 5000 breast cancer survivors will conduct BRCA1, BRCA2, PTEN, CHEK2, and PALB2 genetic susceptibility genes testing, fill in clinical and genetic information forms, and collect family history. Mutation rate of BRCA1/2 and other genetic susceptibility genes in Chinese community breast cancer population will be measured. Logistic regression will be performed to establish a prediction model for the probability of BRCA1/2 and other gene mutations. Kin-Cohort method will be used to calculate the penetrance of breast cancer and other common malignancies in BRCA1/2 and other genetic mutation carriers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • breast cancer patients of any age;
  • both male and female;
  • the subjects signed the informed consent to participate in the study and abide by the study procedure before being selected.

排除标准

  • healthy people or other malignant tumor patients without breast cancer;
  • unable to interview the investigator and sign the informed consent due to any reason;
  • it is impossible to collect peripheral blood or oral mucosa samples for any reason.

结局指标

主要结局

The frequency of pathogenic or likely pathogenic variants of BRCA1/2 and other genetic susceptibility genes in Chinese community breast cancer population

时间窗: 1 year

The frequency of pathogenic or likely pathogenic variants and 95% confidence intervals of BRCA1/2 and other genetic susceptibility genes in Chinese community breast cancer population will be measured. After stratifying according to the different clinical characteristics of the patients, chi-square tests will be use to compare the mutation rates of BRCA1/2 gene in different subgroups.

次要结局

  • Prediction model of Genetic Susceptibility Gene (BRCA1/2 etc) mutation probability(1 year)
  • Breast cancer penetrance of Genetic Susceptibility Gene (BRCA1/2 etc) carriers(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhen Hu

Professor

Fudan University

研究点 (1)

Loading locations...

相似试验